A primary undifferentiated pleomorphic sarcoma of the lumbosacral region harboring a LMNA-NTRK1 gene fusion with durable clinical response to crizotinib: a case report
Abstract Background High-grade spindle cell sarcomas are a subtype of rare, undifferentiated pleomorphic sarcomas (UPSs) for which diagnosis is difficult and no specific treatment strategies have been established. The limited published data on UPSs suggest an aggressive clinical course, high rates o...
Main Authors: | Ning Zhou, Reinhold Schäfer, Tao Li, Meiyu Fang, Luying Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-08-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12885-018-4749-z |
Similar Items
-
Clinicopathological findings of pediatric NTRK fusion mesenchymal tumors
by: Jeongwan Kang, et al.
Published: (2020-09-01) -
Complete response to crizotinib in a metastatic adenocarcinoma of unknown primary harboring MET amplification and NTRK1 co-occurring mutation
by: Yao J, et al.
Published: (2019-05-01) -
Pleomorphic undifferentiated sarcoma: A case of a giant renal mass
by: Nusret Can Çilesiz, et al.
Published: (2018-03-01) -
Unclassified mesenchymal sarcoma with NTRK1-KHDRBS1 gene fusion: a case report of long-term tumor-free survival with crizotinib treatment
by: Weijie Chen, et al.
Published: (2021-04-01) -
Head and Neck Tumors: Management of Primary Undifferentiated Pleomorphic Sarcoma
by: Luis-Alejandro Boccalatte, et al.
Published: (2019-11-01)